81 related articles for article (PubMed ID: 3085356)
1. Effect of the beta-2 adrenergic agonist fenoterol on the release of leukotrienes and prostaglandin D2 from human lung parenchyma.
Viganò T; Sautebin L; Crivellari MT; Galli G; Mezzetti M; Folco GC
Wien Klin Wochenschr; 1986 Feb; 98(4):120-22. PubMed ID: 3085356
[TBL] [Abstract][Full Text] [Related]
2. Release of leukotrienes, induced by the Ca++ ionophore A23187, from human lung parenchyma in vitro.
Sautebin L; Viganò T; Grassi E; Crivellari MT; Galli G; Berti F; Mezzetti M; Folco G
J Pharmacol Exp Ther; 1985 Jul; 234(1):217-21. PubMed ID: 2989505
[TBL] [Abstract][Full Text] [Related]
3. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
Hughes JM; Seale JP; Temple DM
Eur J Pharmacol; 1983 Nov; 95(3-4):239-45. PubMed ID: 6197312
[TBL] [Abstract][Full Text] [Related]
4. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro".
Viganò T; Sautebin L; Magni F; Crivellari MT; Paganelli R; Galli G; Berti F; Folco G
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):109-15. PubMed ID: 3020580
[TBL] [Abstract][Full Text] [Related]
5. Mast cells and mast cell mediators in models of airway disease.
Peters SP; Naclerio RM; Freeland HS; Togias A; Schleimer RP; MacGlashan DW; Kagey-Sobotka A; Fox CC; Adkinson NF; Lichtenstein LM
Prog Clin Biol Res; 1985; 199():153-61. PubMed ID: 2999818
[No Abstract] [Full Text] [Related]
6. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.
Schleimer RP; Davidson DA; Lichtenstein LM; Adkinson NF
J Immunol; 1986 Apr; 136(8):3006-11. PubMed ID: 3082976
[TBL] [Abstract][Full Text] [Related]
7. Differences in the formation and metabolism of leukotrienes B4 and C4 in the human lung.
Kumlin M; Dahlén SE; Granström E
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1018-22. PubMed ID: 2823552
[No Abstract] [Full Text] [Related]
8. Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.
Kosaka Y; Kawabe H; Ishii A
Agents Actions; 1987 Jun; 21(1-2):32-7. PubMed ID: 2442981
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid metabolites in the healthy and diseased lung.
Newman JH; Sheller JR
Am J Med Sci; 1984 Sep; 288(2):75-80. PubMed ID: 6091454
[No Abstract] [Full Text] [Related]
10. Formation of prostaglandins and leukotrienes by human lung tissue in vitro after activation by the calcium ionophore A23187.
Zijlstra FJ; Naaktgeboren M; Mons H; Vincent JE
Eur J Clin Invest; 1987 Aug; 17(4):325-9. PubMed ID: 2822430
[TBL] [Abstract][Full Text] [Related]
11. The interaction of ethanol and exogenous arachidonic acid in the formation of leukotrienes and prostaglandin D2 in mastocytoma cells.
Westcott JY; Murphy RC
Prostaglandins; 1983 Aug; 26(2):223-39. PubMed ID: 6316419
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacology of the leukotrienes].
Sirois P; Borgeat P
J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antigen and Ca++-ionophore-induced peptidoleukotriene release from guinea pig lung preparations using high-performance liquid chromatography.
Cheng JB; Eskra JD; Pillar J
J Pharmacol Exp Ther; 1987 Jun; 241(3):786-92. PubMed ID: 3110408
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of human mast cells.
Schulman ES; Kagey-Sobotka A; MacGlashan DW; Adkinson NF; Peters SP; Schleimer RP; Lichtenstein LM
J Immunol; 1983 Oct; 131(4):1936-41. PubMed ID: 6194221
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostaglandin D2 in modulating histamine release from human basophils.
Peters SP; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
J Pharmacol Exp Ther; 1984 Feb; 228(2):400-6. PubMed ID: 6198512
[TBL] [Abstract][Full Text] [Related]
17. Adenosine and eicosanoid release from immunologically challenged human lung fragments.
Viganò T; Toia A; Galli G; Berti F; Crivellari MT; Mezzetti M; Folco GC
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():992-6. PubMed ID: 2823581
[No Abstract] [Full Text] [Related]
18. Mediator release from human lung under conditions of reduced oxygen tension.
Peters SP; Lichtenstein LM; Adkinson NF
J Pharmacol Exp Ther; 1986 Jul; 238(1):8-13. PubMed ID: 2425080
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid metabolites during nasal challenge.
Brown MS; Peters SP; Adkinson NF; Proud D; Kagey-Sobotka A; Norman PS; Lichtenstein LM; Naclerio RM
Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):179-83. PubMed ID: 3099812
[TBL] [Abstract][Full Text] [Related]
20. [Lipoxygenase reaction and leukotrienes].
Shimizu T
Seikagaku; 1986 Feb; 58(2):92-117. PubMed ID: 3011926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
